← Back to events
ActiveBusinessLegal

Novo Nordisk is suing Eli Lilly over ads it says mislead consumers on weight loss drug efficacy

What happened

Novo says Lilly's TV and social media campaigns cite outdated trial data to make Zepbound and Mounjaro look more effective than rival injections

Summary assembled by rule from the sources below

Sources